Last update :
07/04/2025
References   References 4911  
Type : Manufacturer

Research teams :
Authors :
Title : Glofitamab (Columvi®) - Résumé des caractéristiques du produit
Reference :

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionGlofitamab Anticancer drug
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 30°C Not specified
24 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,45% 0,1 >> 0,6 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,45% 0,1 >> 0,6 mg/ml 30°C Not specified
24 Hour
Stability in solutions Polyethylene Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polyethylene Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 30°C Not specified
24 Hour
Stability in solutions Polypropylene Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polypropylene Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 30°C Not specified
24 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 2-8°C Not specified
72 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 0,1 >> 0,6 mg/ml 30°C Not specified
24 Hour

  Mentions Légales